It is possible that BM-resident CD69+ TTE and circulating CD69- TTE cooperate in anti-tumor immunity based on the inverse relationship between CD69+ TTE and CD69- TTE observed within the BM-resident T cell compartment in NDMM patients (12). Here, CD69 is linked to neoplasm.